Nanotechnology approaches for inhalation treatment of lung diseases.

Local administration of therapeutics by inhalation for treatment of lung diseases has the ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and therefore enhance the efficacy of the treatment, limit the penetration of nebulized therapeutic agent(s) into the bloodstream and consequently decrease adverse systemic side effects of the treatment. Nanotechnology allows for a further enhancement of the treatment efficiency. The present review analyzes modern therapeutic approaches of inhaled nanoscale-based pharmaceutics for the detection and treatment of various lung diseases.

[1]  T. Minko,et al.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[2]  E. Alton,et al.  Cystic Fibrosis Gene Therapy in the UK and Elsewhere , 2015, Human gene therapy.

[3]  J. Kopeček,et al.  The Influence of Cytotoxicity of Macromolecules and of VEGF Gene Modulated Vascular Permeability on the Enhanced Permeability and Retention Effect in Resistant Solid Tumors , 2004, Pharmaceutical Research.

[4]  M. Radomski,et al.  Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[5]  M. Zhang,et al.  Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage , 2010, Drug Delivery and Translational Research.

[6]  K. Johnston,et al.  In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  T. Minko,et al.  Biodegradable Janus Nanoparticles for Local Pulmonary Delivery of Hydrophilic and Hydrophobic Molecules to the Lungs , 2014, Langmuir : the ACS journal of surfaces and colloids.

[8]  G. Smaldone,et al.  Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition. , 2014, Journal of Aerosol Medicine.

[9]  T. Minko,et al.  Antibodies and peptides in cancer therapy. , 2006, Critical reviews in therapeutic drug carrier systems.

[10]  S. Durham,et al.  Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial , 1999, The Lancet.

[11]  T. Minko,et al.  Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA , 2011, Journal of drug targeting.

[12]  J. Nah,et al.  Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. , 2011, International journal of pharmaceutics.

[13]  S. Dharap,et al.  Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Conly L. Rieder,et al.  Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied , 2008, The Journal of cell biology.

[15]  P. Anderson,et al.  Aerosolized Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Therapy in Metastatic Cancer , 2003, American journal of clinical oncology.

[16]  D. Gill,et al.  Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis , 2000, Gene Therapy.

[17]  R. Banerjee,et al.  Proapoptotic lipid nanovesicles: synergism with paclitaxel in human lung adenocarcinoma A549 cells. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[18]  G. Leitinger,et al.  Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Enzo Terreno,et al.  Image guided therapy: the advent of theranostic agents. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[20]  H. Kirchner,et al.  Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. , 2004, Stem cells and development.

[21]  T. Minko.  Drug targeting to the colon with lectins and neoglycoconjugates. , 2004, Advanced drug delivery reviews.

[22]  J. Carballido,et al.  Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2 , 2007, Anti-cancer drugs.

[23]  H. Mansour,et al.  Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery , 2012, Lung.

[24]  B. Giraudeau,et al.  Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. , 2011, Journal of aerosol medicine and pulmonary drug delivery.

[25]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Clancy,et al.  Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. , 2004, Chest.

[27]  V. Torchilin,et al.  Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. , 1994, ImmunoMethods.

[28]  SUSANA PEREIRA,et al.  Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine , 2004, J. Comput. Chem..

[29]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[30]  P. Low,et al.  Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. , 2013, Archives of pathology & laboratory medicine.

[31]  Hiroshi Terada,et al.  Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. , 2009, Colloids and surfaces. B, Biointerfaces.

[32]  D. Porteous,et al.  A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis , 2013, Thorax.

[33]  M. Inbar,et al.  Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  Ji-Eun Kim,et al.  Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice , 2011, Journal of veterinary science.

[35]  Vladimir P Torchilin,et al.  Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[36]  S. Gettinger,et al.  Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.

[37]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[38]  Yang Wang,et al.  In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[39]  G. Mainelis,et al.  Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention , 2014, Cancer biology & medicine.

[40]  E. Kleinerman,et al.  Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group , 2010, Clinical Cancer Research.

[41]  T. Minko,et al.  Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol. , 2002, Journal of applied physiology.

[42]  Sandra N. Ekdawi,et al.  Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications. , 2015, International journal of pharmaceutics.

[43]  M. Kris,et al.  Development of inhalational agents for oncologic use. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  G. Mainelis,et al.  Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[45]  T. Minko,et al.  Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[47]  K. Lyseng-Williamson,et al.  Budesonide/Formoterol , 2012, Drugs.

[48]  Huixin He,et al.  Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. , 2011, Current drug delivery.

[49]  S. Hosseinkhani,et al.  In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung. , 2011, International journal of pharmaceutics.

[50]  K. Reuhl,et al.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[51]  J. Graybill,et al.  Inhaled Voriconazole for Prevention of Invasive Pulmonary Aspergillosis , 2009, Antimicrobial Agents and Chemotherapy.

[52]  Alexandre A. Vetcher,et al.  Nonviral Nanoscale-Based Delivery of Antisense Oligonucleotides Targeted to Hypoxia-Inducible Factor 1α Enhances the Efficacy of Chemotherapy in Drug-Resistant Tumor , 2008, Clinical Cancer Research.

[53]  T. Minko,et al.  New generation of liposomal drugs for cancer. , 2006, Anti-cancer agents in medicinal chemistry.

[54]  E. Kleinerman,et al.  Aerosol interleukin‐2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis , 2014, Pediatric blood & cancer.

[55]  Paul Galvin,et al.  Magnetic core-shell nanoparticles for drug delivery by nebulization , 2013, Journal of Nanobiotechnology.

[56]  C. Berkland,et al.  Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration , 2009, Pharmaceutical Research.

[57]  Samantha A. Meenach,et al.  Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[58]  M. Kris,et al.  Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs , 2007, Clinical Cancer Research.

[59]  M. Schwaiblmair,et al.  Drug Induced Interstitial Lung Disease , 2012, The open respiratory medicine journal.

[60]  S. Kagamimori,et al.  Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. , 1993, British Journal of Cancer.

[61]  J. Brachmann,et al.  Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System , 2014, Journal of Cancer.

[62]  J. Kopeček,et al.  Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. , 2000, Biomacromolecules.

[63]  V. Soldatenkov,et al.  Targeted proapoptotic anticancer drug delivery system. , 2007, Molecular pharmaceutics.

[64]  S. Betigeri,et al.  Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. , 2008, Bioconjugate chemistry.

[65]  C. Verschraegen,et al.  Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies , 2004, Clinical Cancer Research.

[66]  G. Winter,et al.  Protein stability in pulmonary drug delivery via nebulization. , 2015, Advanced drug delivery reviews.

[67]  M. D. Reed,et al.  Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model , 2013, British Journal of Cancer.

[68]  Nikos K. Karamanos,et al.  Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology , 2012, International journal of molecular sciences.

[69]  T. Kissel,et al.  Controlled pulmonary drug and gene delivery using polymeric nano-carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Alan B. Watts,et al.  Preclinical evaluation of tacrolimus colloidal dispersion for inhalation. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[71]  Hongtao Yu,et al.  The spindle checkpoint, aneuploidy, and cancer , 2004, Oncogene.

[72]  T. Minko,et al.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. , 2008, Nanomedicine.

[73]  W. Berger,et al.  Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[74]  J. Nah,et al.  Glucosylated polyethylenimine as a tumor-targeting gene carrier , 2005, Archives of pharmacal research.

[75]  S. Siegel,et al.  Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.

[76]  Maxime Henry,et al.  Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization. , 2015, Small.

[77]  J. Morales,et al.  Surfactants: their critical role in enhancing drug delivery to the lungs. , 2011, Therapeutic delivery.

[78]  Keith L Black,et al.  MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain. , 2015, ACS nano.

[79]  S. Dharap,et al.  Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[80]  P. Diot,et al.  The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors , 2011, Pharmaceutical Research.

[81]  Thomas Ferkol,et al.  Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. , 2007, Human gene therapy.

[82]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[83]  J. Li,et al.  Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii , 2006, Antimicrobial Agents and Chemotherapy.

[84]  Scott B. Johnson,et al.  Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model. , 2010, International journal of pharmaceutics.

[85]  Min Zhang,et al.  Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing , 2011, ACS nano.

[86]  Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy , 2014, Pharmaceutical Research.

[87]  Gediminas Mainelis,et al.  Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance , 2010, Proceedings of the National Academy of Sciences.

[88]  K. Johnston,et al.  Nebulization of nanoparticulate amorphous or crystalline tacrolimus--single-dose pharmacokinetics study in mice. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[89]  Jong-Choon Kim,et al.  Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats. , 2006, Regulatory toxicology and pharmacology : RTP.

[90]  Samantha A. Meenach,et al.  High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies , 2014, AAPS PharmSciTech.

[91]  T. Minko,et al.  Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. , 2009, Biomacromolecules.

[92]  T. Minko,et al.  Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[93]  S. Stenglein,et al.  Inhalation devices for long-acting β2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD , 2007, Current medical research and opinion.

[94]  Alexandre A. Vetcher,et al.  Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug , 2009, Pharmaceutical Research.

[95]  Benjamin C. Tang,et al.  Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. , 2010, Biomaterials.

[96]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[97]  L. Yarmus,et al.  Defense mechanisms of the respiratory system and aerosol production systems. , 2014, Medicinal chemistry (Shariqah (United Arab Emirates)).

[98]  Leslie Y Yeo,et al.  Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform. , 2015, Biomicrofluidics.

[99]  K. Hardwick,et al.  The spindle checkpoint , 2006, Journal of Cell Science.

[100]  R. Löbenberg,et al.  Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[101]  P. Zarogoulidis,et al.  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients , 2012, Investigational New Drugs.

[102]  T. Minko,et al.  Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[103]  C. Lehr,et al.  Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges. , 2013, The Lancet. Respiratory medicine.

[104]  D. Escande,et al.  Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. , 2004, Nucleic acids research.

[105]  T. Noah,et al.  Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[106]  M. Franco-Molina,et al.  WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth , 2009, Cancer Gene Therapy.

[107]  P. Diot,et al.  Aerosolized chemotherapy. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[108]  D. Owen,et al.  Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[109]  P. Low,et al.  Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma. , 2013, Molecular pharmaceutics.

[110]  K. Rowland,et al.  A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma: An NCCTG Study , 2008, American journal of clinical oncology.

[111]  Chao Zhang,et al.  Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice. , 2012, Fitoterapia.

[112]  V. Torchilin,et al.  TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.

[113]  Katherine Kho,et al.  A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles. , 2012, International journal of pharmaceutics.

[114]  T. Minko,et al.  Nanotechnology approaches for personalized treatment of multidrug resistant cancers. , 2013, Advanced drug delivery reviews.

[115]  B. Pitard,et al.  Effect of fractalkine-Fc delivery in experimental lung metastasis using DNA/704 nanospheres , 2011, Cancer Gene Therapy.

[116]  Josephine E. Phillips,et al.  On the airways , 1942 .

[117]  Yang Wang,et al.  Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense , 2004, Cancer Research.

[118]  A. Čihák.  Biological effects of 5-azacytidine in eukaryotes. , 1974, Oncology.

[119]  H. Chan,et al.  Advances in Device and Formulation Technologies for Pulmonary Drug Delivery , 2014, AAPS PharmSciTech.

[120]  C. Cho,et al.  Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy. , 2014, Journal of biomedical materials research. Part A.

[121]  D Tomlinson,et al.  Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. , 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

[122]  R. Gorlick,et al.  Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung , 2013, Pediatric blood & cancer.

[123]  Min Zhang,et al.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.

[124]  F. Schué,et al.  Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) , 2012 .

[125]  J. Kopeček,et al.  Immunogenicity of coiled-coil based drug-free macromolecular therapeutics. , 2014, Biomaterials.

[126]  S. Dharap,et al.  Molecular targeting of drug delivery systems to cancer. , 2004, Current drug targets.

[127]  I. Haririan,et al.  Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery , 2010, International journal of nanomedicine.

[128]  Li-xi Yang,et al.  New molecular mechanisms of action of camptothecin-type drugs. , 2006, Anticancer research.

[129]  Simone R. Carvalho,et al.  Formulations for pulmonary administration of anticancer agents to treat lung malignancies. , 2011, Journal of aerosol medicine and pulmonary drug delivery.

[130]  J. Clancy,et al.  A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. , 2001, Human gene therapy.

[131]  K. Darwiche,et al.  Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer. , 2013, Translational lung cancer research.

[132]  H. Heinzer,et al.  Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. , 2003, Folia biologica.

[133]  Huixin He,et al.  Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. , 2010, ACS nano.

[134]  F. Ahmad,et al.  Aerodynamics and deposition effects of inhaled submicron drug aerosol in airway diseases. , 2012, Recent Patents on Inflammation & Allergy Drug Discovery.

[135]  G. Peters,et al.  Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung , 2007, Clinical Cancer Research.

[136]  Daniela Traini,et al.  Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery , 2012, Pharmaceutical Research.

[137]  I Gonda,et al.  Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. , 1990, Critical reviews in therapeutic drug carrier systems.

[138]  Bernhard Gleich,et al.  Targeted delivery of magnetic aerosol droplets to the lung , 2007, Nature Nanotechnology.

[139]  H. Montaseri,et al.  Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. , 2010, Colloids and surfaces. B, Biointerfaces.

[140]  H. Chan,et al.  Delivery of inhalation drugs to children for asthma and other respiratory diseases. , 2014, Advanced drug delivery reviews.

[141]  J. Sloan,et al.  Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[142]  토마스 이. 타라라,et al.  Respirable agglomerates of porous carrier particles and micronized drug , 2014 .

[143]  T. Minko,et al.  LHRH-targeted nanoparticles for cancer therapeutics. , 2010, Methods in molecular biology.

[144]  T. Minko,et al.  A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. , 2004, Biochemical pharmacology.

[145]  K. Reuhl,et al.  Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. , 2012, Nanomedicine.

[146]  V. Torchilin,et al.  Liposomes in diagnosis and treatment of cardiovascular disorders. , 2012, Methodist DeBakey cardiovascular journal.

[147]  C. Posch,et al.  Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients , 2014, British Journal of Cancer.

[148]  A. Hochberg,et al.  Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth , 2011, PloS one.

[149]  T. Minko,et al.  Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug , 2013, Clinical Cancer Research.

[150]  Wean Sin Cheow,et al.  Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles. , 2012, International journal of pharmaceutics.